Dear readers! We present to your attention the third issue of the LOGISTICS journal. First of all, we would like to draw readers' attention to our new partner R1 Development, a development company that creates a new generation environment and specializes in the construction of industrial, logistics, commercial and residential real estate. One of the projects of R1 Development is the Druzhba industrial park network.
Dear readers! We present to your attention the third issue of the LOGISTICS journal for 2025. Our editorial staff, like all our colleagues, is preparing for the TransRussia 2025 exhibition, the largest event in the industry. In this issue, we have prepared an interview with Natalia Lomunova, Director of TransRussia, with whom we are talking about a flexible approach, new participants and digital services. We continue the series of articles from P.V.
Dear readers! We present to your attention the first issue of the LOGISTICS journal in 2025. First of all, we would like to draw readers' attention to our new partner R1 Development, a development company that creates a new generation environment and specializes in the construction of industrial, logistics, commercial and residential real estate. One of the projects of R1 Development is the Druzhba industrial park network.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
According to the results of 2021, Protek Group topped the list of pharmaceutical companies in the Expert-400 rating, which was published on 10 October in issue No. 41 of Expert magazine.
The Group ranked 67th in the overall list with sales volume of over 314 billion rubles. Pulse Pharmaceutical Company was ranked 78th in the Expert-400 rating, and Katren was 87th.
“Based on the results of 2021, Protek Group demonstrated revenue growth of 7.06% compared to 2020. The most impressive results (+20.9%) were shown by the Production segment represented by Sotex and Rafarma. The revenue of the Retail segment exceeded 18%, while the revenue of the Distribution segment amounted to more than 3%. Protek Group plans to strengthen its position in the pharmaceutical market and in the segment of medical services through development of ecosystem, which will provide the patient with a full range of necessary services to maintain health and high quality of life, ranging from diagnosis and medical care to necessary goods for health and beauty”, - noted Vadim Muzyaev, President of Protek Group.
 |
 |
